Back to Search Start Over

Glycemic Control and Insulin Improve Muscle Mass and Gait Speed in Type 2 Diabetes: The MUSCLES-DM Study.

Authors :
Sugimoto K
Ikegami H
Takata Y
Katsuya T
Fukuda M
Akasaka H
Tabara Y
Osawa H
Hiromine Y
Rakugi H
Source :
Journal of the American Medical Directors Association [J Am Med Dir Assoc] 2021 Apr; Vol. 22 (4), pp. 834-838.e1. Date of Electronic Publication: 2020 Dec 02.
Publication Year :
2021

Abstract

Objectives: Type 2 diabetes is a risk factor for sarcopenia. Evidence on the prevention of sarcopenia using blood glucose-lowering therapy is limited. We aimed to examine the relationship between changes in glycemic control and sarcopenia and the effect of antidiabetic agents against sarcopenia in patients with type 2 diabetes.<br />Design: We conducted an observational longitudinal study.<br />Setting and Participants: In total, 588 Japanese patients with diabetes of an ongoing multicenter study completed 1-year follow-up measurements for sarcopenia and clinical data.<br />Methods: The data set of the Multicenter Study for Clarifying Evidence for Sarcopenia in patients with Diabetes Mellitus (the MUSCLES-DM study) was analyzed.<br />Results: During the follow-up period, the frequency of sarcopenia marginally increased, and the means of skeletal muscle mass index (SMI), handgrip strength, and gait speed did not show any changes. However, on dividing into 5 groups depending on the degree of changes in glycated hemoglobin (HbA <subscript>1c</subscript> ) value, the patients with a decrease of ≥1% in HbA <subscript>1c</subscript> exhibited a significant increase in SMI. Our analysis revealed similar results for gait speed but not handgrip strength. Using the multiple linear regression model, we identified that a ≥1% decrease in HbA <subscript>1c</subscript> value was an independent determinant of the changes in SMI and gait speed. We also determined that insulin use at baseline was an independent factor for the changes in SMI.<br />Conclusions and Implications: Correction of poor glycemic control and use of insulin were significantly associated with the increase in skeletal muscle mass or gait speed in Japanese patients with type 2 diabetes. The current finding increases our understanding of the importance of glycemic control for the prevention of cardiovascular diseases and sarcopenia.<br /> (Copyright © 2020 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1538-9375
Volume :
22
Issue :
4
Database :
MEDLINE
Journal :
Journal of the American Medical Directors Association
Publication Type :
Academic Journal
Accession number :
33278348
Full Text :
https://doi.org/10.1016/j.jamda.2020.11.003